V2M (p.Val2Met) variant of HTR2C (5-hydroxytryptamine receptor 2C)

V2M (p.Val2Met) in HTR2C (5-hydroxytryptamine receptor 2C) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of HTR2C-related disorder. The available variant effect predictions contribute to a CATVariant prioritization score of 0.27 / 1. The record also includes population frequency data and structural context.

V2M (p.Val2Met) variant details